NASDAQ:SNOA

Sonoma Pharmaceuticals (SNOA) Stock Forecast, Price & News

$1.40

+0.43 (+44.33%)

(As of 06/9/2023 ET)

Compare

Today's Range: $1.16
▼
$1.52
50-Day Range: $0.92
▼
$1.40
52-Week Range: $0.76
▼
$4.19

Volume: 28.78 million shs
Average Volume: 33,075 shs
Market Capitalization: $6.51 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock

Sonoma Pharmaceuticals, Inc. engages in developing and producing Stabilized Hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. Its products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.

Receive SNOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SNOA Stock News Headlines

June 9, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

June 8, 2023 | finanznachrichten.de

Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

June 10, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

June 8, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

May 21, 2023 | thestreet.com

Williams-Sonoma Could Be Headed for More Trouble

May 11, 2023 | marketwatch.com

8-K: Sonoma Pharmaceuticals, Inc.

April 27, 2023 | americanbankingnews.com

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Short Interest Down 25.1% in April

April 19, 2023 | finance.yahoo.com

Benign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share Price

June 10, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

April 14, 2023 | travel.usnews.com

Getting Around Sonoma

April 12, 2023 | nytimes.com

Track Covid-19 in Sonoma County, California

April 11, 2023 | finanznachrichten.de

Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

April 11, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

April 4, 2023 | travel.usnews.com

Sonoma Plaza

March 28, 2023 | finanznachrichten.de

Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

March 28, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

March 28, 2023 | seekingalpha.com

Regeneron to pay Sonoma $75M upfront in pact to develop autoimmune disease drugs

March 2, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

February 14, 2023 | finanznachrichten.de

Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

February 14, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

January 31, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

January 25, 2023 | marketwatch.com

Sonoma Pharma Shares Rise 82% After Pricing Agreement for Microcyn Rx Products

January 25, 2023 | benzinga.com

These Four Companies Are Attracting Investors Following Recent News

January 25, 2023 | finanznachrichten.de

Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn Rx Products

January 25, 2023 | investorplace.com

Why Is Sonoma Pharmaceuticals (SNOA) Up 70% Today?

January 25, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

January 4, 2023 | finance.yahoo.com

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

See More Headlines

SNOA Price History

30 days | 90 days | 365 days | Advanced Chart

SNOA Company Calendar

Last Earnings: 11/14/2019
Today: 6/10/2023
Next Earnings (Estimated): 7/12/2023
Fiscal Year End: 3/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SNOA
CUSIP: N/A
CIK: 1367083
Web: www.sonomapharma.com
Phone: (800) 759-9305
Fax: 707-283-0551
Employees: 14
Year Founded: 1999

Profitability

EPS (Most Recent Fiscal Year): ($2.19)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,090,000.00
Net Margins: -54.05%
Pretax Margin: -55.95%
Return on Equity: -81.76%
Return on Assets: -36.84%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.86
Quick Ratio: 2.13

Sales & Book Value

Annual Sales: $12.63 million
Price / Sales: 0.52
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.81 per share
Price / Book: 0.50

Miscellaneous

Outstanding Shares: 4,650,000
Free Float: 4,212,000
Market Cap: $6.51 million
Optionable: Not Optionable
Beta: 1.16

Social Links

Key Executives

Amy M. Trombly
Chief Executive Officer & Director

Bruce Thornton
Chief Operating Officer & Secretary

Jerome J. Dvonch
Chief Financial Officer

Key Competitors

View All Competitors

Institutional Ownership

Renaissance Technologies LLC
Sold 32,500 shares on 5/12/2023
Ownership: 0.903%

View All Institutional Transactions

SNOA Stock - Frequently Asked Questions

How have SNOA shares performed in 2023?: Sonoma Pharmaceuticals' stock was trading at $1.12 at the start of the year. Since then, SNOA shares have increased by 25.0% and is now trading at $1.40.
View the best growth stocks for 2023 here.
When is Sonoma Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 12th 2023.
View our SNOA earnings forecast.
How were Sonoma Pharmaceuticals' earnings last quarter?: Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) released its quarterly earnings results on Thursday, November, 14th. The company reported ($0.91) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.18) by $0.27. The company had revenue of $4.97 million for the quarter. Sonoma Pharmaceuticals had a negative net margin of 54.05% and a negative trailing twelve-month return on equity of 81.76%.
What other stocks do shareholders of Sonoma Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sonoma Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), VelocityShares Daily 2x VIX Short-Term ETN (TVIX), Sorrento Therapeutics (SRNE), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Amarin (AMRN), Pfizer (PFE), Nabriva Therapeutics (NBRV), Verastem (VSTM) and Vaxart (VXRT).

What is Sonoma Pharmaceuticals' stock symbol?: Sonoma Pharmaceuticals trades on the NASDAQ under the ticker symbol "SNOA."
Who are Sonoma Pharmaceuticals' major shareholders?: Sonoma Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.90%).
View institutional ownership trends.
How do I buy shares of Sonoma Pharmaceuticals?: Shares of SNOA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Sonoma Pharmaceuticals' stock price today?: One share of SNOA stock can currently be purchased for approximately $1.40.
How much money does Sonoma Pharmaceuticals make?: Sonoma Pharmaceuticals (NASDAQ:SNOA) has a market capitalization of $6.51 million and generates $12.63 million in revenue each year. The company earns $-5,090,000.00 in net income (profit) each year or ($2.19) on an earnings per share basis.
How can I contact Sonoma Pharmaceuticals?: Sonoma Pharmaceuticals' mailing address is 645 MOLLY LANE SUITE 150, WOODSTOCK GA, 30189. The official website for the company is www.sonomapharma.com. The company can be reached via phone at (800) 759-9305, via email at dmcfadden@sonomais.com, or via fax at 707-283-0551.

This page (NASDAQ:SNOA) was last updated on 6/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial